complete remission achieved. Hypertension persisted and was treated with enalapril and frusemide. Soon after diagnosis, we tried to correct the severe hypercholesterolaemia and hypertriglyceridaemia by dietary means, but this failed and we began simvastatin 20 mg daily. Blood lipids declined, and Table 1 shows that this trend antedated remission of the nephropathy. After six months of simvastatin (by which time the patient was in remission) HDL had risen to 1.3 mmol/L and LDL had fallen to 5.5 mmol/L. COMMENT Minimal change nephropathy is the most frequent cause of nephrotic syndrome in children and young adults. Some cases are associated with allergic diatheses, malignant disease (especially Hodgkin's), viral infection, drug therapy and immunizations3'4.The patient reported here received a year's treatment for allergy before her nephropathy was diagnosed. When treated with steroids, more than 95% of children under 16 with minimal change nephropathy lose their proteinuria within 8 weeks, though many relapse when steroids are tapered or withdrawn. During the disease, most patients have some combination of increased cholesterol and LDL, low HDL, and high triglycerides that in adults might demand treatment to prevent cardiovascular disease5. Should such lipid disorders be treated? The question requires further study in a range of renal diseases, but our experience in this case associated with a bee sting indicates that an HMG-CoA reductase inhibitor can be effective in nephrotic syndrome due to secondary as well as primary nephropathy. Oesophageal achalasia secondary to pleural mesothelioma The lung did not re-expand after thoracentesis. A thoracic computed tomography (CT) scan showed atelectasis of the right inferior lobe, a thickened visceral pleura covering the entire lung as well as a dilated oesophagus. On gastroscopy the oesophagus was seen to be greatly dilated, with retained food, and the gastro-oesophageal junction opened only when mild pressure was applied by the endoscope. The mucosal surface was normal. Bronchoscopy showed thick mucopurulent secretions filling the entire right main bronchus. Neither examination suggested malignant disease.
Initial diagnosis was oesophageal achalasia, complicated by chronic aspiration and a pulmonary abscess in the right lower lobe. The patient underwent pneumatic dilatation of the lower oesophageal sphincter and inferior lobectomy. The lower lobe was necrotic and the entire lung was encapsulated by fibrinous tissue. On histological examination this tissue proved to be a malignant pleural mesothelioma. During surgery no parietal or mediastinal invasion was seen, and the chest CT scan showed no signs of tumour extension near the oesophagus. The patient rapidly lost weight and died six months after diagnosis. There was no history of exposure to asbestos. COMMENT The incidence of achalasia is 0.4-0.6 per 100 000 populationl. Affecting both sexes with equal frequency, the condition usually arises between the third and the fifth decade. Hallmarks are oesophageal aperistalsis and abnormal lower oesophageal sphincter relaxation. Patients usually present with dysphagia (98%) to solids and liquids, weight loss (62%), a feeling of retrosternal fullness, regurgitation (78%) of undigested food while recumbent, mild chest pain (48%) and cough (30%)2. Progression of dysphagia from solids to soft foods to liquids, the hallmark of malignant disease, is not characteristic of achalasia. Clinical history and a barium swallow showing a dilated oesophagus tapering smoothly into a bird's beak are usually diagnostic. Endoscopy should be performed even if the barium swallow is typical, to exclude adenocarcinoma of the cardia and to evaluate the state of the mucosa before any therapeutic intervention. Manometry establishes the diagnosis2.
Primary achalasia, by far the commoner variety, is characterized by degeneration of the oesophageal myenteric plexus3, decreased concentration of vasoactive intestinal peptide and reduced nitric oxide synthase activity. Secondary achalasia may be caused by Chagas' disease, amyloidosis, vagotomy or familial adrenal insufficiency or neoplasia, or neoplasm2. Achalasia secondary to cancer is rare and accounts for 2-4% of cases described2. Adenocarcinoma of the gastro-oesophageal junction is the malignancy most frequently associated with achalasia (70%), followed by lung cancer (10%), lymphoma (9%), hepatocarcinoma (4%), pancreatic adenocarcinoma (2%), prostatic adenocarcinoma (2%), lymphangioma of the oesophagus (2%), squamous carcinoma of the oesophagus (2%), and mesothelioma (2%)l 2.
Cancer can induce achalasia by direct invasion of the oesophageal wall thus decreasing oesophageal distensibility; another suggested mechanism is destruction of the myenteric plexus by tumour cells4. At operation our patient did not seem to have extension of his mesothelioma into the mediastinum, and there were no signs of infiltration on the chest scan. Schulze et a].5 suggested that secondary achalasia could be caused by a paraneoplastic peripheral neuropathy, but on physical examination the patient showed no signs of such neuropathy. Another paraneoplastic mechanism targeted on the oesophageal myenteric complexes may be at the root of this association, but this remains to be proved. Current therapy of achalasia includes pneumatic dilatation, surgical oesophagomyotomy and drugs decreasing lower oesophageal sphincter pressure such as nitrates, beta-agonists and calcium channel blockers2. Oesophagomyotomy is more effective but pneumatic dilatation is less invasive and cheaper. Had a lobectomy not been necessary, we would not have diagnosed the underlying malignancy. A malignant lesion should always be suspected in patients over 50 years of age who have severe dysphagia of recent onset (less than six months) with substantial weight loss4.
